Literature DB >> 25233827

Dystrophic hyaloid artery remnants and other abnormalities in a buphthalmic eye with retinoblastoma.

Frederick A Jakobiec1, Ruju Rai2, Alia Rashid2, Justin Kanoff3, Shizuo Mukai3.   

Abstract

Partial persistence of the hyaloid artery unaccompanied by hyperplastic primary vitreous has not been previously reported in association with retinoblastoma. We describe an 18-month-old child with such a finding who had a retinoblastoma that was undifferentiated, extensively necrotic, heavily calcified, and completely filled the eyeball. The enucleated globe harbored a nonperfused, fossilized remnant of the hyaloid artery due to DNA/calcium deposition in the vascular wall. This structure inserted into a lenticular, extracapsular, fibrous plaque corresponding to a Mittendorf dot. The tumor had induced a placoid cataractous lens, obliterated the anterior and posterior chambers, caused glaucoma leading to buphthalmos, and extended into the optic nerve and extraocularly to involve the orbit. We conclude that the retinoblastoma arose early in ocular morphogenesis, at around 4 months gestation, when the programmed involution of the hyaloid artery begins. This process would typically end at 7-8 months gestation, but was aborted by the tumor. The patient died 6 weeks after surgery without receiving further treatment because of the parents' resistance.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  buphthalmos; cataract; crystalline lens; deformation of lens; dystrophic calcification; hyaloid artery; lens capsule; lens epithelium; retinoblastoma

Mesh:

Year:  2014        PMID: 25233827     DOI: 10.1016/j.survophthal.2014.05.002

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  1 in total

1.  Atypical intravitreal growth of retinoblastoma with a multi-branching configuration.

Authors:  Sachiko Nishina; Satoshi Katagiri; Atsuko Nakazawa; Chikako Kiyotani; Tadashi Yokoi; Noriyuki Azuma
Journal:  Am J Ophthalmol Case Rep       Date:  2017-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.